Company CHA Vaccine Research Institute

Equities

A261780

KR7261780001

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
4,855 ^KRW	+0.62%		-2.71%	-14.07%

01-08	CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy	MT
2023	Cha Vaccine Research Institute Co., Ltd. announced that it has received KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	CI

CHA Vaccine Research Institute Co Ltd is a Korea-based company principally engaged in the vaccines and immunotherapy research business based on based on adjuvant platform technology. The Company is engaged in the research and development (R&D) of premium preventive vaccines, therapeutic vaccines and immunotherapies such as hepatitis B virus (HBV) vaccines, chronic HBV vaccines and others. The Company is also engaged in the vaccines distribution and licensing out services.

KRW in Million	2022	Weight	2023	Weight	Delta
Vaccines and Diagnostic Reagents 100.0 %	179	100.0 %	294	100.0 %	+63.87%

KRW in Million	2022	Weight	2023	Weight	Delta
Overseas 100.0 %	179	100.0 %	294	100.0 %	+63.87%

Managers	Title	Age	Since
Jeong-Seon Yeom CEO	Chief Executive Officer	62	30/09/00
Jung-Ki Cho PSD	President	54	31/12/18
Seung-Rae Kim AUD	Comptroller/Controller/Auditor	66	31/08/20

Members of the board	Title	Age	Since
Min-Sik Park BRD	Director/Board Member	54	29/02/20
Jung-Jae Koh BRD	Director/Board Member	70	28/02/17
Dae-Gyu Oh BRD	Director/Board Member	71	28/02/21
Jeong-Seon Yeom CEO	Chief Executive Officer	62	30/09/00
Dong-Cheol Shin BRD	Director/Board Member	54	28/02/21
Yong-Ha Baek BRD	Director/Board Member	56	27/03/22
Jung-Ki Cho PSD	President	54	31/12/18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	26,816,748	15,907,174 ( 59.32 %)	0	59.32 %

Name	Equities	%	Valuation
CHABIOTECH CO.,LTD. 38.37 %	10,289,296	38.37 %	37 M ₩
CHA-MEDITECH CO., LTD. 0.7192 %	192,864	0.7192 %	692 139 ₩
CHA Vaccine Research Institute Co., Ltd. ESOA 0.5641 %	151,261	0.5641 %	542 836 ₩
Jeong-Seon Yeom 0.5429 %	145,585	0.5429 %	522 467 ₩
Jung-Ki Cho 0.4102 %	110,000	0.4102 %	394 761 ₩
Byung-chul Ahn 0.2759 %	73,993	0.2759 %	265 542 ₩
Jung-Jae Koh 0.2112 %	56,650	0.2112 %	203 302 ₩
Ja-hoon Choi 0.0895 %	23,999	0.0895 %	86 126 ₩

CHA Vaccine Research Institute Co., Ltd.

560 Dunchon-daero Jungwon-gu

13230, Seongnam-si

http://www.chavaccine.com

address CHA Vaccine Research Institute(A261780)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
CHA VACCINE RESEARCH INSTITUTE	-14.07%	95.9M
VERTEX PHARMACEUTICALS INCORPORATED	+7.52%	113B
REGENERON PHARMACEUTICALS, INC.	+11.38%	106B
ARGENX SE	+0.79%	22.27B
BIONTECH SE	-12.64%	22.22B
GENMAB A/S	-4.41%	19.43B
WUXI APPTEC CO., LTD.	-37.85%	17.87B
BEIGENE, LTD.	-8.58%	17.24B
NEUROCRINE BIOSCIENCES, INC.	+7.77%	14.29B
SAREPTA THERAPEUTICS, INC.	+37.41%	12.52B

Bio Therapeutic Drugs